107 results match your criteria: "Paediatric Research Institute[Affiliation]"
Nat Rev Genet
April 2023
Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX, USA.
Repetitive elements in the human genome, once considered 'junk DNA', are now known to adopt more than a dozen alternative (that is, non-B) DNA structures, such as self-annealed hairpins, left-handed Z-DNA, three-stranded triplexes (H-DNA) or four-stranded guanine quadruplex structures (G4 DNA). These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability. In addition, recent studies have revealed a role for these alternative structures in triggering error-generating DNA repair processes, thereby actively enabling genome plasticity.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
November 2022
From the Department of Pediatric Neurology (E.M.W.), Olgahospital/Klinikum Stuttgart; Department of Pediatric Neurology (H.S.T., A. Bertolini, K.R.), Witten/Herdecke University, Datteln, Germany; Department of Pediatric I (M. Baumann, C.L.), Pediatric Neurology, Medical University of Innsbruck, Innsbruck, Austria; LMU Klinikum (A. Blaschek), Hauner Children´s Hospital, Munich; Division of Pediatric Neurology (A.M.), Department of Pediatrics, Medical University of Leipzig; Department of General Pediatrics (M.K.), Neonatology and Pediatric Cardiology, University Childrens Hospital, Heinrich-Heine- University Duesseldorf, Germany; Department of Neurology (B.K.), Medical University Vienna, Austria; Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada; Department of Neuropediatrics (M.P.), Children's Hospital DRK Siegen, Germany; Clinical Department of Neurology (K.S., M.R.), Medical University of Innsbruck, Austria; Division of Pediatric Neurology (M. Schimmel), Childrens Hospital, Medical University of Augsburg; Department of Neuropediatrics and Social Pediatrics (C.T.), University Hospital for Children and Adolescent Medicine, Ruhr-University Bochum; Division of Neuropediatrics and Social Pediatrics (S.W.), Childrens Hospital, Cologne; Division of Pediatric Neurology (G.W.), Department of Pediatrics, Asklepios Klinik Nord, Heidberg, Germany; Department of Pediatric Neurology (B.A.), Hacettepe University Faculty of Medicine, Ankara, Turkey; Department of Pediatrics (N.B.), University Hospital Zagreb, Medical University Zagreb, Croatia; Department of Pediatric Neurology (C.B.), Kinderkrankenhaus St. Marien gGmbH, Landshut, Germany; Division of Pediatric Pulmonology (M. Breu), Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna; Department of Pediatric Neurology (P.B.), Ostschweizer Kinderspital, St. Gallen, Switzerland; Department of Pediatric Neurology (A.D.M.), Centre for Neuromuscular Disorders, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen; Department of Pediatric Neurology (K.D.), Children's Hospital Kassel; Department of Neuropediatrics and Muscle Disorders (M.E.), Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Department of Paediatrics and Adolescent Medicine (A.E.), Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria; Department of Pediatric and Adolescent Medicine (M.F.), Medical University Vienna, Austria; Department of Pediatrics (U.G.-S.), LKH Medical University Graz, Austria; Department of Pediatric Neurology (A.H.), University Children's Hospital, University of Zurich; Zentrum für Kinderneurologie AG (T.I.), Zurich, Schwitzerland; Charité Universitätsmedizin Berlin (E.K.), Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Germany; Department of Pediatrics (J.K.), Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria; Division of Pediatric Neurology (G.K.), Department of Pediatrics, Caritas-Hospital Bad Mergentheim, Germany; Department of Pediatrics and Adolescent Medicine (S.L.), Hospital Dritter Orden, Munich, Germany; Department of Pediatric Neurology (G.L.), Children's Hospital Altona, Hamburg, Germany; Paediatric Neurology and Neurophysiology Unit (M.N., S.S.), Department of Women's and Children's Health, University Hospital of Padova, Italy; Neuroimmunology Group (M.N., S.S.), Paediatric Research Institute "Città della Speranza," Padova, Italy; Department of Neuropediatrics and Muscle Disorders (A.P.), University Medical Center, Faculty of Medicine, University of Freiburg, Germany; Medical University of Vienna (E.R.-F.), Department of Pediatrics; Department of Neuropediatrics (E.R.-F.), St. Anna Children`s Hospital; Department of Social Medicine (D.R.), Donauspital, Vienna, Austria; Department of Pediatrics (M. Salandin), Division of Pediatric Neurology, Hospital Bozen, Italy; Department of Pediatrics (J.-U.S.), Division of Pediatric Neurology, Gemeinschaftskrankenhaus Herdecke, Medical University Witten, Herdecke, Germany; Department of Pediatrics (J. Stoffels), Division of Neuropediatrics, KJF Klinikum Josefinum, Augsburg, Germany; Neurology Department of Children's University Hospital (J. Strautmanis), Riga Stradins University, Riga, Latvia; Center for Pediatric and Teenage Health Care (D.T.), Child Neurology, Sankt Augustin, Germany; Department of Neuropediatrics (V.T.), University Hospital Carl Gustav Carus, Technische Universität Dresden; and Department of Pediatric Neurology (N.U.), Children's Hospital, Medical University Greifswald, Germany.
Background And Objective: The spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorder (MOGAD) comprises monophasic diseases such as acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), and transverse myelitis and relapsing courses of these presentations. Persistently high MOG antibodies (MOG immunoglobulin G [IgG]) are found in patients with a relapsing disease course. Prognostic factors to determine the clinical course of children with a first MOGAD are still lacking.
View Article and Find Full Text PDFLancet Microbe
November 2022
Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518038, China; Paediatric Research Institute, Shenzhen Children's Hospital, Shenzhen 518038, China. Electronic address:
J Neurol Neurosurg Psychiatry
July 2022
Division of Clinical Neurophysiology and Epilepsy Centre, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
J Pediatr Pharmacol Ther
July 2022
Child Abuse and Neglect Crisis Unit (MR, PF, MRR), University Hospital of Padua, Padua, Italy.
Infect Drug Resist
June 2022
Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518038, People's Republic of China.
Background: The rising resistance to carbapenems in Gram-negative bacteria worldwide poses a major clinical and public health risk. This study aimed to characterise carbapenem- and colistin-resistance genes, and located on IncX4 plasmid in MDR , isolated from paediatric patients undergoing chemotherapy as a result of leukaemia.
Methods: In this study, six carbapenem-resistant strains of were isolated from two paediatric patients under chemotherapy treatment (1.
Front Pediatr
May 2022
Paediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
Front Pediatr
April 2022
Paediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
Neuronal surface antibody syndromes (NSAS) are an expanding group of autoimmune neurological diseases, whose most frequent clinical manifestation is autoimmune encephalitis (AE). Anti-NMDAR, anti-LGI1, and anti-CASPR2 autoimmunity represent the most described forms, while other NSAS are rarer and less well-characterized, especially in children. We carried out a systematic literature review of children with rare NSAS (with antibodies targeting D2R, GABAAR, GlyR, GABABR, AMPAR, amphiphysin, mGluR5, mGluR1, DPPX, IgLON5, and neurexin-3alpha) and available individual data, to contribute to improve their clinical characterization and identification of age-specific features.
View Article and Find Full Text PDFVirol J
April 2022
Beijing Key Laboratory of Paediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Paediatrics (Capital Medical University), National Clinical Research Center for Respiratory Diseases, Beijing Paediatric Research Institute, Department of Paediatric Critical Care Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Background: Rhinovirus is a common viral aetiology of upper respiratory infection and is mostly associated with common cold or flu-like illness. Although rhinovirus has been recognized as a pathogen for lower respiratory infections in severe cases credited to advances in molecular detection, central nervous system involvement and multiorgan dysfunction are extremely rare.
Case Presentation: A previously healthy 10-year-old girl developed fever, sore throat and conjunctive injection after contact with an upper respiratory infection patient, followed by seizures, haematuria, and severe diarrhoea.
Front Cell Infect Microbiol
April 2022
Beijing Key Laboratory of Paediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Paediatrics (Capital Medical University), Beijing Paediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
WU polyomavirus (WUPyV) is a novel member of the family recently detected in respiratory tract specimens. So far, it has not been proven whether WUPyV is a real causative agent for respiratory diseases. In this study, we described two patients with fatal infection who had WUPyV detected in their nasopharyngeal swabs.
View Article and Find Full Text PDFInfect Drug Resist
March 2022
Department of Oncology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, 518000, People's Republic of China.
Background: Since 2015, plasmid-borne has been reported in various bacterial strains in the clinical setting globally. However, the transmission mechanisms of this gene in are not well defined. This study aimed to characterize the genomic features of a ST34 isolate, which carried a , mapped to a carbapenemase and extended spectrum β-lactamase encoding gene located on the IncX4 plasmid.
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
July 2022
Department of Woman and Child Health, Paediatric Research Institute, University of Padua, Padua, Italy.
Children with congenital and acquired heart disease may be exposed to relatively high lifetime cumulative doses of ionizing radiation from necessary medical invasive and non-invasive imaging procedures. Although these imaging procedures are all essential to the care of these complex paediatric population and have contributed to meaningfully improved outcomes in these patients, exposure to ionizing radiation is associated with potential risks, including an increased lifetime attributable risk of cancer. The goal of this manuscript is to provide a comprehensive review of radiation dose management and cardiac computed tomography performance in the paediatric population with congenital and acquired heart disease, to encourage informed imaging to achieve indication-appropriate study quality at the lowest achievable dose.
View Article and Find Full Text PDFBMC Pediatr
March 2022
Beijing Paediatric Research Institute, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, National Centre for Children's Health, Beijing, 100045, China.
Background: Retinopathy of prematurity (ROP) remains a leading cause of childhood blindness worldwide. This study aimed to investigate whether supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs) in parenteral nutrition may have beneficial effects on ROP in preterm infants.
Methods: A total of 89 preterm infants, admitted to Neonatal Intensive Care Unit (NICU) in Anhui Provincial Children's Hospital from September 2017 to August 2020, were recruited in the study.
BMJ
January 2022
Cluster for Health Services Research, Norwegian Institute of Public Health, Postboks 222, Skøyen, N-0213 Oslo, Norway.
Objectives: To explore whether and for how long use of healthcare services is increased among children and adolescents after covid-19.
Design: Before and after register based study.
Setting: General population of Norway.
Eur J Paediatr Neurol
January 2022
Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Importance: Overall, immunotherapy has been shown to improve outcomes and reduce relapses in individuals with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE); however, the superiority of specific treatments and combinations remains unclear.
Objective: To map the use and safety of immunotherapies in individuals with NMDARE, identify early predictors of poor functional outcome and relapse, evaluate changes in immunotherapy use and disease outcome over the 14 years since first reports of NMDARE, and assess the Anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score.
Data Sources: Systematic search in PubMed from inception to January 1, 2019.
Infect Drug Resist
September 2021
Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China.
Aim: We investigated the clonal diversity of carbapenemase-producing isolates from the Shenzhen Children's Hospital, China, and drew conclusions on the clinical and public health impact of these isolates as multidrug-resistant.
Methods: From January 2014 to December 2018, a total number of 36 unique carbapenemase-producing clinical isolates of were collected out of 900 clinical isolates in paediatric patients from the Shenzhen Children's Hospital, China. After carbapenemase production confirmation, antimicrobial susceptibility, resistance determinants and phylogenetic relationship were determined.
Front Cell Dev Biol
July 2021
Beijing Key Laboratory of Paediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, National Key Discipline of Paediatrics (Capital Medical University), Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing Paediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
N6-methyladenosine (mA) is a ubiquitous RNA modification in eukaryotes. It plays important roles in the translocation, stabilization and translation of mRNA. Many recent studies have shown that the dysregulation of mA modification is connected with diseases caused by pathogenic viruses, and studies on the role of mA in virus-host interactions have shown that mA plays a wide range of regulatory roles in the life cycle of viruses.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
July 2021
From the Paediatric Neurology and Neurophysiology Unit (M.N.), Department of Women's and Children's Health, University Hospital of Padova; Neuroimmunology Group (M.N.), Paediatric Research Institute "Città della Speranza," Padova, Italy; Department of Paediatrics (T.T.), Neurology Service, KK Women's and Children's Hospital, Singapore; School of Biomedical Engineering & Imaging Sciences (M.E.), King's College London; Children's Neurosciences (M.E.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, United Kingdom; Department of Pediatric Neurology (B.A.), Hacettepe University, Ankara, Turkey; Neuroimmunology Program (T.A.), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona; Pediatric Neuroimmunology Unit (T.A.), Neurology Department, Sant Joan de Déu (SJD) Children's Hospital, University of Barcelona, Spain; Alberta Children's Hospital Research Institute (S.M.B.), Department of Pediatrics, Cumming School of Medicine, University of Calgary; Division of Rheumatology (T.C.), Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; Assistance Publique-Hôpitaux de Paris (K.D.), Pediatric Neurology Department, University Hospitals Paris Saclay, Bicêtre Hospital, France; French Reference Network of Rare Inflammatory Brain and Spinal Diseases (K.D.), Le Kremlin Bicêtre, France and European Reference Network-RITA; Departments of Neurology and Pediatrics (W.G.), Stanford University and Lucile Packard Children's Hospital, Palo Alto, CA; Division of Pediatric Neurology (G.G.), Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, GA; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Neuroinflammation (Y.H.), Queen Square MS Centre, UCL Institute of Neurology, University College London; Department of Paediatric Neurology (Y.H.), Great Ormond Street Hospital for Children, London, United Kingdom; Department of Pediatrics (Y.J.), Peking University First Hospital, Beijing, China; Department of Pediatrics (B.C.L.), Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, South Korea; Department of Pediatrics (E.M.), Section Rheumatology, Co-appointment in the Section of Neurology and Developmental Neuroscience, Texas Children's Hospital, Baylor College of Medicine, Houston; Division of Paediatric Neurology (A.N.), Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town; Faculty of Health Sciences (A.N.), University of Cape Town Neuroscience Institute, South Africa; Department of Neurology (R.N.), Erasmus Medical Center, Rotterdam, the Netherlands; Department of Pediatric Neurology (K.R.), Children's Hospital Datteln, University Witten/Herdecke, Germany; Department of Brain and Neural Science (H.S.), Tokyo Metropolitan Institute of Medical Science, Japan; Department of Pediatrics (Neurology Division) (S.S.), Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, India; Department of Neurology (S.N.T.), National Pediatric Hospital Dr. J. Garrahan, Buenos Aires, Argentina; Department of Pediatrics (H.A.V.M.), Duke University, Durham, NC; Department of Neurology (E.W.), Children's National Medical Center, Washington, DC; Neuropaediatric Unit (R.W.), Karolinska University Hospital, Stockholm, Sweden; Department of Neurology (A.K.Y.), Icahn School of Medicine at Mount Sinai, New York; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, United Kingdom; Neuroimmunology Program (J.D.), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, Philadelphia; Institució Catalana de Recerca i Estudis Avançats (ICREA) (J.D.), Barcelona, Spain; Children's Neurosciences (M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust; King's Health Partners Academic Health Science Centre (M.L.); Faculty of Life Sciences and Medicine (M.L.), King's College Hospital, United Kingdom; and Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
Objective: To create an international consensus treatment recommendation for pediatric NMDA receptor antibody encephalitis (NMDARE).
Methods: After selection of a panel of 27 experts with representation from all continents, a 2-step Delphi method was adopted to develop consensus on relevant treatment regimens and statements, along with key definitions in pediatric NMDARE (disease severity, failure to improve, and relapse). Finally, an online face-to-face meeting was held to reach consensus (defined as ≥75% agreement).
J Neurol Neurosurg Psychiatry
March 2022
Multiple Sclerosis Centre of the Veneto Region (CeSMuV), University Hospital of Padua, Padua, Italy.
Clin Exp Rheumatol
February 2022
Department of Rheumatology, Beijing Children’s Hospital, Capital Medical University, National Centre for Children’s Health, Beijing,China.
Objectives: Juvenile dermatomyositis (JDM) is an autoimmune disease characterised by a great heterogeneity in its clinical manifestations. In this study, we aimed to investigate the association between different clinical subtypes, laboratory data, and myositis antibodies of JDM.
Methods: A total of 132 JDM patients were enrolled and their medical records were retrospectively reviewed and autoantibodies tested.
Eur J Cancer
July 2021
SIREDO Oncology Center, Institute Curie, PSL University, Paris, France.
Pediatr Neurol
July 2021
Paediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padua, Padua, Italy; Neuroimmunology Group, Paediatric Research Institute Città della Speranza, Padua, Italy; Department of Neurosciences (DNS), University of Padua, Padua, Italy.
Sleep Med
June 2021
Department of Otolaryngology, Head and Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China. Electronic address:
Objectives: To investigate alterations in neurocognitive, attention, paediatric sleep questionnaire (PSQ) scores and whole brain white matter (WM) integrity between children with mild and severe obstructive sleep apnoea (OSA) according to sex and whether these changes are associated with OSA severity.
Methods: Fifty-seven children (36 males and 21 females) diagnosed with OSA were recruited for this study. Children of both sexes were divided into mild (male-MG, female-MG) and severe (male-SG, female-SG) groups according to OSA severity.
Acta Paediatr
July 2021
Paediatric Research Institute, The Faculty of Medicine, University of Oslo, Oslo, Norway.